Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes.

Nicola Stefano Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Patrick Maisonneuve(European Institute of Oncology), Cristina Novembrino(University of Milan), Silvia Ippolito(University of Insubria), Fabrizia Bamonti Catena(University of Milan)
PubMed
May 1, 2003
Cited by 10

Related Papers

Hereditary Pancreatitis and the Risk of Pancreatic Cancer
|JNCI Journal of the National Cancer Institute|1997|986
Development and Validation of a Food Frequency Questionnaire in Spain
|International Journal of Epidemiology|1993|933
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394